6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
24m ago	Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
25m ago	The Trade Desk Powers Open Internet Growth with DramaBox Short Drama Partnership
1h ago	Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
1h ago	Sun Pharma signs Definitive Agreement to Acquire Organon
5h ago	Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

About

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) — investor relations, events, news, and company updates on 6ix.

Latest News

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call

Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance

Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

Financials

Revenue

$296.15 M

Market Cap

$577.23 M

P/E Ratio

23.60

EPS

0.15

Community Chat

Ask AI